Biomarkers
Longevity research has made significant strides in identifying biological markers, or biomarkers, that help predict lifespan and healthspan. Biomarkers for longevity are measurable indicators of an individual's health status and biological aging process. These markers can often indicate the functional capacity of various systems within the body and predict the risk of age-related diseases. By understanding and monitoring these biomarkers, individuals and healthcare providers can make informed decisions to potentially delay aging and improve overall health.
The Importance of Biomarkers
Biomarkers are valuable not only for predicting longevity but also for providing targets for interventions that may improve the healthspan. By understanding which biomarkers are associated with age-related decline, researchers and clinicians can work to develop strategies to address these issues before they lead to disease.
Monitoring and Improving Biomarkers
Regular health check-ups and blood tests are common methods for monitoring these biomarkers. Lifestyle interventions such as diet, exercise, stress management, and sleep hygiene have been shown to positively influence these markers. In some cases, pharmaceutical interventions may also be used to manage biomarker levels and mitigate health risks.
Sinclair's Top 5 Biomarkers For Longevity
Dr. David Sinclair, a leading researcher in the field of genetics and longevity, has identified several key biomarkers that are indicative of one's biological age and longevity. These biomarkers provide insights into the aging process and can serve as targets for anti-aging interventions.[1]
| Biomarker | Relevance to Longevity |
|---|---|
| Glucose Level HbA1c | Glycated hemoglobin (HbA1c) levels reflect average blood glucose concentrations over the previous three months. Higher levels are associated with an increased risk of age-related diseases such as diabetes and cardiovascular disease. |
| Inflammatory markers, especially cardiovascular like CRP should be low | Chronic inflammation is linked to many diseases of aging. C-reactive protein (CRP) is a marker of inflammation, and high levels may predict cardiovascular events and mortality. |
| Cholesterol markers including Lipoprotein(a) | Cholesterol levels, particularly low-density lipoprotein (LDL) and lipoprotein(a), are predictors of cardiovascular health. Elevated levels are associated with an increased risk of atherosclerosis and heart disease. |
| Hormone levels (testosterone) | Hormones like testosterone can influence muscle mass, bone density, and overall metabolic health. Low levels in men have been associated with increased morbidity and mortality. |
| Albumin | Albumin levels can indicate nutritional status and organ function. Low albumin may be a marker for poor health outcomes and increased risk of death. |
Todo
- 2023, Correction to: Blood biomarker profiles and exceptional longevity: comparison of centenarians and non‑centenarians in a 35‑year follow‑up of the Swedish AMORIS cohort [2]
- 2021, Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring [3]
References
- ↑ https://www.youtube.com/shorts/IPv7zHrRY7Q
- ↑ Murata S et al.: Correction to: Blood biomarker profiles and exceptional longevity: comparison of centenarians and non‑centenarians in a 35‑year follow‑up of the Swedish AMORIS cohort. Geroscience 2023. (PMID 37923875) [PubMed] [DOI]
- ↑ Hartmann A et al.: Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring. Front Genet 2021. (PMID 34093670) [PubMed] [DOI] [Full text] Aging affects most living organisms and includes the processes that reduce health and survival. The chronological and the biological age of individuals can differ remarkably, and there is a lack of reliable biomarkers to monitor the consequences of aging. In this review we give an overview of commonly mentioned and frequently used potential aging-related biomarkers. We were interested in biomarkers of aging in general and in biomarkers related to cellular senescence in particular. To answer the question whether a biological feature is relevant as a potential biomarker of aging or senescence in the scientific community we used the PICO strategy known from evidence-based medicine. We introduced two scoring systems, aimed at reflecting biomarker relevance and measurement effort, which can be used to support study designs in both clinical and research settings.